or Try an Advanced Search...

    Technical Analysis for IPSC - Century Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 2.41 -5.49% -0.14
    IPSC closed down 5.49 percent on Monday, July 1, 2024, on 87 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical IPSC trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Stochastic Buy Signal Bullish -5.49%
    Pocket Pivot Bullish Swing Setup -5.49%
    Volume Surge Other -5.49%
    Doji - Bullish? Reversal -5.49%
    Outside Day Range Expansion -5.49%
    Wide Bands Range Expansion -5.49%
    Oversold Stochastic Weakness -5.49%
    Pocket Pivot Bullish Swing Setup -4.74%
    Older End-of-Day Signals for IPSC ...

       Recent Intraday Alerts

    Alert Time
    Lower Bollinger Band Support about 5 hours ago
    Fell Below Previous Day's Low about 8 hours ago
    60 Minute Opening Range Breakdown about 8 hours ago
    Down 5% about 8 hours ago
    Down 3% about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    IPSC Chart by TradingView
    Basic chart:

    Profile

    Century Therapeutics is harnessing the power of adult stem cells to develop curative cell therapy products for cancer that we believe will allow us to overcome the limitations of first-generation cell therapies. Our genetically engineered, iPSC-derived iNK and iT cell products are designed to specifically target hematologic and solid tumor cancers. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provides an opportunity to advance the course of cancer care.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Life Sciences Biology Stem Cell Cell Therapy Cell Biology Induced Stem Cells Cancer Care Cloning

    Is IPSC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 20 Century Therapeutics: Cell Therapy Biotech With Expanded Potential Of CNTY-101
    Jun 18 Century Therapeutics files to sell 7.87M shares of common stock for holders
    Jun 3 Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting
    May 15 Century Therapeutics files to sell 15.87M shares of common stock for holders
    May 10 Century Therapeutics Inc (IPSC) Q1 2024 Earnings: Aligns with EPS Projections Amid Strategic ...
    May 10 Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting
    May 9 Century Therapeutics GAAP EPS of -$0.45
    May 9 Century Therapeutics, Inc. (IPSC) Reports Q1 Loss, Tops Revenue Estimates
    May 9 Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
    Apr 23 Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
    See more IPSC news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.51
    52 Week Low 1.28
    Average Volume 219,259
    200-Day Moving Average 3.00
    50-Day Moving Average 3.01
    20-Day Moving Average 2.91
    10-Day Moving Average 2.69
    Average True Range 0.27
    RSI (14) 34.21
    ADX 14.19
    +DI 14.27
    -DI 17.35
    Chandelier Exit (Long, 3 ATRs) 2.66
    Chandelier Exit (Short, 3 ATRs) 3.18
    Upper Bollinger Bands 3.48
    Lower Bollinger Band 2.33
    Percent B (%b) 0.07
    BandWidth 39.69
    MACD Line -0.18
    MACD Signal Line -0.12
    MACD Histogram -0.0575
    Fundamentals Value
    Market Cap 144.2 Million
    Num Shares 59.8 Million
    EPS -2.20
    Price-to-Earnings (P/E) Ratio -1.10
    Price-to-Sales 103.41
    Price-to-Book 1.21
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.76
    Resistance 3 (R3) 2.79 2.70 2.70
    Resistance 2 (R2) 2.70 2.61 2.69 2.68
    Resistance 1 (R1) 2.56 2.56 2.51 2.53 2.66
    Pivot Point 2.47 2.47 2.45 2.45 2.47
    Support 1 (S1) 2.32 2.38 2.28 2.29 2.16
    Support 2 (S2) 2.23 2.32 2.22 2.14
    Support 3 (S3) 2.09 2.23 2.12
    Support 4 (S4) 2.06